Clinical Trial Update: Preemptive Analgesia Of Dexmedetomidine Reduces Per-operation Pain [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating preemptive dexmedetomidine for reducing per-operation pain in noncardiac surgery; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: China International Neuroscience Institution | Conditions: Pain Management, Noncardiac Surgery | Phase 4 | Status: NOT_YET_RECRUITING